Screened drugs were further molecular docked against previously identified epilepsy targets voltage-gated sodium channel subunit α2 (Nav1.2), GABA receptor α1-β1,and voltage-gated calcium channel α1G (Cav3.1) [20]. This evidence concerns the gene SCN2A and epilepsy.